CME

Forecast & Rating17 analysts currently cover CME, with about 41.2% giving a positive rating — meaning they expect the stock to rise. The average price target is $283.60, about 6.1% upside from the current price of $267.21. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 73.1% of past price targets were eventually met, which adds credibility. For you, this means institutional views on CME are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Sep 15, 2026; for reference only and not investment advice.